Evidence map›Paper›PMID 40976660›Full record

ArticleBMJ open2025

Finding the optimal regimen for

Tiffany Jong, Timothy Baird, Helen Louise Barr, Scott Bell, Theophile Bigirumurame, Kara Brady, Andrew Burke, Joshua Byrnes, Daan Caudri, Julia E Clark and 24 more

Registry-linked trialAbstract readClinical Trial Protocol
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04310930 (Finding the Optimal Regimen for Mycobacterium Abscessus Treatment), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04310930 phase2 / phase3recruitingnot on this map

Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT)

TypeinterventionalSponsorThe University of QueenslandRan2020 to 2030Enrolled300ConditionsPulmonary Disease Due to Mycobacteria (Diagnosis)ArmsAmikacin, Tigecycline, Imipenem, Cefoxitin, Azithromycin
3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Predictors of treatment initiation in nontuberculous mycobacterial pulmonary disease: a real-life retrospective analysis.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors.

Tiffany JongThe University of Queensland, Brisbane, Queensland, Australia tiffany.jong@health.qld.gov.au.ORCID http://orcid.org/0009-0004-6540-3289
Timothy BairdSunshine Coast University Hospital, Sunshine Coast, Queensland, Australia.
Helen Louise BarrNottingham Respiratory Biomedical Research Centre, University of Nottingham, Nottingham, UK.
Scott BellThe University of Queensland, Brisbane, Queensland, Australia.
Theophile BigirumurameNewcastle University Faculty of Medical Sciences, Newcastle upon Tyne, UK.ORCID http://orcid.org/0000-0003-2387-4918
Kara BradyThe University of Queensland, Brisbane, Queensland, Australia.
Andrew BurkeThe University of Queensland, Brisbane, Queensland, Australia.
Joshua ByrnesGriffith University Centre for Applied Health Economics, Southport, Queensland, Australia.
Daan CaudriDepartment of Pediatrics, Division of Respiratory Medicine and Allergy, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.
Julia E ClarkThe University of Queensland, Brisbane, Queensland, Australia.
Lachlan J M CoinThe University of Melbourne Department of Microbiology and Immunology, Parkville, Victoria, Australia.
Felicia GohThe University of Queensland, Brisbane, Queensland, Australia.
Keith GrimwoodMenzies Health Institute Queensland, Griffith University School of Medicine and Dentistry, Gold Coast, Queensland, Australia.
Daniel HicksThe University of Queensland, Brisbane, Queensland, Australia.
Kaushala JayawardanaMurdoch Children's Research Institute Clinical Epidemiology and Biostatistics Unit, Parkville, Victoria, Australia.
Sri JoshiMurdoch Children's Research Institute Clinical Epidemiology and Biostatistics Unit, Parkville, Victoria, Australia.
Katherine LeeMurdoch Children's Research Institute Clinical Epidemiology and Biostatistics Unit, Parkville, Victoria, Australia.
Tavs QvistRigshospitalet, Kobenhavn, Denmark.
David ReidThe Prince Charles Hospital Department of Thoracic Medicine, Chermside, Queensland, Australia.
Megan RiceThe University of Queensland, Brisbane, Queensland, Australia.
Jason A RobertsThe University of Queensland Centre for Clinical Research, Herston, Queensland, Australia.
Geraint RogersFlinders University, Adelaide, South Australia, Australia.
Claire ShackletonWal-Yan Respiratory Research Centre, The Kids Research Institute Australia, Nedlands, Perth, Australia.
Peter D SlyThe University of Queensland, Brisbane, Queensland, Australia.
Alan R SmythQueen's University Belfast School of Medicine Dentistry and Biomedical Sciences, Belfast, UK.
Luke StevensMurdoch Children's Research Institute Clinical Epidemiology and Biostatistics Unit, Parkville, Victoria, Australia.
Rebecca StockwellThe University of Queensland, Brisbane, Queensland, Australia.
Abdullah TariqueThe University of Queensland, Brisbane, Queensland, Australia.
Steven TaylorInfection and Immunity, South Australian Health and Medical Research Institute Limited, Adelaide, South Australia, Australia.ORCID http://orcid.org/0000-0003-4357-8243
Rachel ThomsonThe University of Queensland, Brisbane, Queensland, Australia.
Harm A W M TiddensDepartment of Pediatrics, Division of Respiratory Medicine and Allergy, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.
Xiao Fang WangMurdoch Children's Research Institute Clinical Epidemiology and Biostatistics Unit, Parkville, Victoria, Australia.
James WasonPopulation Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.ORCID http://orcid.org/0000-0002-4691-126X
Claire WainwrightThe University of Queensland, Brisbane, Queensland, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionMETHODS AND ANALYSIS: FOR ETHICS AND DISSEMINATION: The FOR TRIAL REGISTRATION NUMBERS: NCT04310930, ANZCTR12618001831279, 2020-000050-10, ISRCTN67303903.

Indexed as

Anti-Bacterial AgentsLung DiseasesMycobacterium abscessusMycobacterium Infections, NontuberculousClinical Trials, Phase II as TopicClinical Trials, Phase III as TopicDrug Therapy, CombinationHumansMulticenter Studies as TopicPragmatic Clinical Trials as TopicQuality of LifeRandomized Controlled Trials as TopicAnti-Bacterial Agentsclinical trialcystic fibrosishealth economicslung diseasespulmonary diseasequality of life

Identifiers

PMID40976660
PMCPMC12458872

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.